BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37095322)

  • 1. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma.
    Yao X; Hong JH; Nargund AM; Ng MSW; Heng HL; Li Z; Guan P; Sugiura M; Chu PL; Wang LC; Ye X; Qu J; Kwek XY; Lim JCT; Ooi WF; Koh J; Wang Z; Pan YF; Ong YS; Tan KY; Goh JY; Ng SR; Pignata L; Huang D; Lezhava A; Tay ST; Lee M; Yeo XH; Tam WL; Rha SY; Li S; Guccione E; Futreal A; Tan J; Yeong JPS; Hong W; Yauch R; Chang KT; Sobota RM; Tan P; Teh BT
    Nat Cell Biol; 2023 May; 25(5):765-777. PubMed ID: 37095322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma.
    Schoenfeld DA; Zhou R; Zairis S; Su W; Steinbach N; Mathur D; Bansal A; Zachem AL; Tavarez B; Hasson D; Bernstein E; Rabadan R; Parsons R
    Mol Cancer Res; 2022 Aug; 20(8):1193-1207. PubMed ID: 35412614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PBRM1 bromodomains variably influence nucleosome interactions and cellular function.
    Slaughter MJ; Shanle EK; McFadden AW; Hollis ES; Suttle LE; Strahl BD; Davis IJ
    J Biol Chem; 2018 Aug; 293(35):13592-13603. PubMed ID: 29986887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
    Agaimy A; Amin MB; Gill AJ; Popp B; Reis A; Berney DM; Magi-Galluzzi C; Sibony M; Smith SC; Suster S; Trpkov K; Hes O; Hartmann A
    Hum Pathol; 2018 Jul; 77():139-146. PubMed ID: 29689242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pbrm1 Steers Mesenchymal Stromal Cell Osteolineage Differentiation by Integrating PBAF-Dependent Chromatin Remodeling and BMP/TGF-β Signaling.
    Sinha S; Biswas M; Chatterjee SS; Kumar S; Sengupta A
    Cell Rep; 2020 Apr; 31(4):107570. PubMed ID: 32348751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer.
    Hodges C; Kirkland JG; Crabtree GR
    Cold Spring Harb Perspect Med; 2016 Aug; 6(8):. PubMed ID: 27413115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells.
    Hagiwara M; Fushimi A; Yamashita N; Bhattacharya A; Rajabi H; Long MD; Yasumizu Y; Oya M; Liu S; Kufe D
    Oncogene; 2021 Jul; 40(30):4930-4940. PubMed ID: 34163028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma.
    Nargund AM; Pham CG; Dong Y; Wang PI; Osmangeyoglu HU; Xie Y; Aras O; Han S; Oyama T; Takeda S; Ray CE; Dong Z; Berge M; Hakimi AA; Monette S; Lekaye CL; Koutcher JA; Leslie CS; Creighton CJ; Weinhold N; Lee W; Tickoo SK; Wang Z; Cheng EH; Hsieh JJ
    Cell Rep; 2017 Mar; 18(12):2893-2906. PubMed ID: 28329682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma.
    Chowdhury B; Porter EG; Stewart JC; Ferreira CR; Schipma MJ; Dykhuizen EC
    PLoS One; 2016; 11(4):e0153718. PubMed ID: 27100670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma.
    Gao W; Li W; Xiao T; Liu XS; Kaelin WG
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1027-1032. PubMed ID: 28082722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual Bromodomains of Polybromo-1 Contribute to Chromatin Association and Tumor Suppression in Clear Cell Renal Carcinoma.
    Porter EG; Dykhuizen EC
    J Biol Chem; 2017 Feb; 292(7):2601-2610. PubMed ID: 28053089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer.
    Chabanon RM; Morel D; Eychenne T; Colmet-Daage L; Bajrami I; Dorvault N; Garrido M; Meisenberg C; Lamb A; Ngo C; Hopkins SR; Roumeliotis TI; Jouny S; Hénon C; Kawai-Kawachi A; Astier C; Konde A; Del Nery E; Massard C; Pettitt SJ; Margueron R; Choudhary JS; Almouzni G; Soria JC; Deutsch E; Downs JA; Lord CJ; Postel-Vinay S
    Cancer Res; 2021 Jun; 81(11):2888-2902. PubMed ID: 33888468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chromatin-remodeling subunit Baf200 promotes homology-directed DNA repair and regulates distinct chromatin-remodeling complexes.
    de Castro RO; Previato L; Goitea V; Felberg A; Guiraldelli MF; Filiberti A; Pezza RJ
    J Biol Chem; 2017 May; 292(20):8459-8471. PubMed ID: 28381560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanoma.
    Carcamo S; Nguyen CB; Grossi E; Filipescu D; Alpsoy A; Dhiman A; Sun D; Narang S; Imig J; Martin TC; Parsons R; Aifantis I; Tsirigos A; Aguirre-Ghiso JA; Dykhuizen EC; Hasson D; Bernstein E
    Cell Rep; 2022 Apr; 39(1):110637. PubMed ID: 35385731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PBRM1 bromodomains associate with RNA to facilitate chromatin association.
    De Silva SM; Dhiman A; Sood S; Mercedes KF; Simmons WJ; Henen MA; Vögeli B; Dykhuizen EC; Musselman CA
    Nucleic Acids Res; 2023 May; 51(8):3631-3649. PubMed ID: 36808431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.
    Rao Q; Xia QY; Wang ZY; Li L; Shen Q; Shi SS; Wang X; Liu B; Wang YF; Shi QL; Ma HH; Lu ZF; He Y; Zhang RS; Yu B; Zhou XJ
    Histopathology; 2015 Jul; 67(1):121-9. PubMed ID: 25496315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SWI/SNF chromatin remodeling complexes and cancer.
    Biegel JA; Busse TM; Weissman BE
    Am J Med Genet C Semin Med Genet; 2014 Sep; 166C(3):350-66. PubMed ID: 25169151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation.
    Gu X; Enane F; Tohme R; Schuerger C; Radivoyevitch T; Parker Y; Zuberi E; Przychodzen B; Jha BK; Lindner D; Rini B; Saunthararajah Y
    Cell Rep; 2021 Sep; 36(12):109747. PubMed ID: 34551289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of human chromatin-remodelling PBAF complex bound to a nucleosome.
    Yuan J; Chen K; Zhang W; Chen Z
    Nature; 2022 May; 605(7908):166-171. PubMed ID: 35477757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.
    Miao D; Margolis CA; Gao W; Voss MH; Li W; Martini DJ; Norton C; Bossé D; Wankowicz SM; Cullen D; Horak C; Wind-Rotolo M; Tracy A; Giannakis M; Hodi FS; Drake CG; Ball MW; Allaf ME; Snyder A; Hellmann MD; Ho T; Motzer RJ; Signoretti S; Kaelin WG; Choueiri TK; Van Allen EM
    Science; 2018 Feb; 359(6377):801-806. PubMed ID: 29301960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.